Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Episurf Medical AB (publ)    EPIS B   SE0003491562

EPISURF MEDICAL AB (PUBL)

(EPIS B)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Stockholm
11/23/2020 11/24/2020 11/25/2020 11/26/2020 11/27/2020 Date
1.98(c) 1.954(c) 1.96(c) 2.065(c) 2.21(c) Last
274 340 537 181 313 318 321 460 5 084 685 Volume
-0.90% -1.31% +0.31% +5.36% +7.02% Change
More quotes
Financials
Sales 2020 6,00 M 0,71 M 0,71 M
Net income 2020 -72,8 M -8,58 M -8,58 M
Net cash position 2020 81,0 M 9,55 M 9,55 M
P/E ratio 2020 -5,54x
Yield 2020 -
Sales 2021 11,9 M 1,41 M 1,41 M
Net income 2021 -77,3 M -9,11 M -9,11 M
Net Debt 2021 1,00 M 0,12 M 0,12 M
P/E ratio 2021 -5,61x
Yield 2021 -
Capitalization 409 M 48,1 M 48,2 M
EV / Sales 2020 54,7x
EV / Sales 2021 34,3x
Nbr of Employees 25
Free-Float 89,1%
More Financials
Company
Episurf Medical AB is a Sweden-based medical technology company. It is engaged in the development, manufacture and marketing of implants and surgical drilling templates used in the treatment of local cartilage damage in knee joints. The Company’s product portfolio includes the Episealer, and individually customized implant used as a cartilage replacement for early-stage patients; and Epiguide, a drill guide... 
More about the company
Notations Surperformance© of Episurf Medical AB (publ)
Trading Rating : - Investor Rating :
More Ratings
All news about EPISURF MEDICAL AB (PUBL)
11/27EPISURF MEDICAL : enters into international advisory agreement
AQ
11/26EPISURF MEDICAL : carries out a directed share issue and raises proceeds of SEK ..
AQ
11/13EPISURF MEDICAL : First Episealer® surgery in Scotland performed
AQ
11/04EPISURF MEDICAL : First Episealer® Talus surgery in Scandinavia performed
AQ
10/26DNB MARKETS - EPISURF MEDICAL :  Clinical data strengthens the case
AQ
10/26EPISURF MEDICAL : First Episealer® surgery performed in Asia
AQ
10/23EPISURF MEDICAL : Interim Report 1 July - 30 September 2020
AQ
10/15EPISURF MEDICAL : enters into a distribution agreement for additional markets in..
AQ
10/14EPISURF MEDICAL : Members of the Nomination Committee for Episurf Medical's Annu..
AQ
10/08EPISURF MEDICAL : Episealer® publication available online
AQ
10/01EPISURF MEDICAL : First Episealer® surgery performed in the US
AQ
09/30EPISURF MEDICAL : Results from Swedish multi-centre clinical trial with follow-u..
AQ
09/25EPISURF MEDICAL : Upping Long-Term Sales
AQ
09/21DNB MARKETS - EPISURF MEDICAL : CMD 2020 highlights
AQ
09/16EPISURF MEDICAL : Episealer® surgery scheduled in France
AQ
More news
News in other languages on EPISURF MEDICAL AB (PUBL)
2019EPISURF MEDICAL AB : Veröffentlichung des Quartalsergebnisses
2019EPISURF MEDICAL AB : publication des résultats trimestriels
2019EPISURF MEDICAL AB : Veröffentlichung des Jahresergebnisses
2019EPISURF MEDICAL AB : publication des résultats annuels
2016EPISURF MEDICAL AB : Veröffentlichung des Halbjahresergebnisses
More news
Chart EPISURF MEDICAL AB (PUBL)
Duration : Period :
Episurf Medical AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EPISURF MEDICAL AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts 2
Average target price 4,00 SEK
Last Close Price 2,21 SEK
Spread / Highest target 81,0%
Spread / Average Target 81,0%
Spread / Lowest Target 81,0%
EPS Revisions
Managers
NameTitle
Pål Ryfors Chief Executive Officer
Dennis D. Stripe Chairman
Katarina Flodstrom Chief Operating & Regulatory Officer
Veronica Wallin Chief Financial Officer
Leif Erik Sigfrid Ryd Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
EPISURF MEDICAL AB (PUBL)88.89%48
STRYKER CORPORATION10.89%87 488
SMITH & NEPHEW PLC-20.74%16 921
INSPIRE MEDICAL SYSTEMS, INC.149.28%4 983
VENUS MEDTECH (HANGZHOU) INC.81.87%3 607
GLAUKOS CORPORATION21.35%3 054